Sponsor

Azienda Ospedaliero, Universitaria Pisana

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Azienda Ospedaliero, Universitaria Pisana appears in 23 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials23
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

23 shown
Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes (DIABeat)NCT06333132 · lead sponsor · 2024-09-01
UNKNOWN
Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related ComplicationsNCT07250607 · lead sponsor · 2024-05-01
ACTIVE_NOT_RECRUITING
Evaluation of Lymph Node Analysis Using One Step Nucleic Acid Amplification (OSNA) in Patients With Lung Cancer Who Underwent Robotic Lung Resection, Comparison With Traditional MethodsNCT07301983 · lead sponsor · 2023-05-17
ENROLLING_BY_INVITATION
Sodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 DiabetesNCT06007157 · lead sponsor · 2023-03-01
UNKNOWN
Comparison of Hypothermic Versus Normothermic Ex-vivo Preservation.NCT04744389 · lead sponsor · 2020-12-15
UNKNOWN
Effect of a Brassicaceae-Enriched Diet on Menopausal Symptoms in Women With Breast Cancer Receiving Antiestrogen TherapyNCT07842614 · lead sponsor · 2020-10-30
COMPLETED
Postprandial Glucose Kinetics After Carbohydrate RestrictionNCT07802275 · lead sponsor · 2019-11-01
COMPLETED
sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) StudyNCT04877119 · lead sponsor · 2019-10-14
UNKNOWN
Metabolic Effects of Early Time-restricted Carbohydrate ConsumptionNCT05713058 · lead sponsor · 2019-03-01
COMPLETED
Effects on Glucose Homeostasis of Changes in Plasma Lipoproteins Induced by Nutritional and Pharmacologic StrategiesNCT05213988 · lead sponsor · 2018-07-30
UNKNOWN
Sustained Effects of a Non-glucidic Nutrient Preload on Glucose Tolerance in Type 2 DiabetesNCT02477761 · lead sponsor · 2015-06-01
UNKNOWN
Myocardial Metabolism in Patients With Dilated CardiomyopathyNCT02440217 · lead sponsor · 2015-05-01
UNKNOWN
Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose HomeostasisNCT02342834 · lead sponsor · 2015-01-01
COMPLETED
Metabolic Effects of the Manipulation of Nutrient Sequence in the Main Meals in Type 2 Diabetic PatientsNCT02442024 · lead sponsor · 2014-01-01
UNKNOWN
Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and SurveillanceNCT07855679 · collaborator · 2026-06-19
RECRUITING
Predictors of Emergency Department Use in Frail PatientsNCT07259499 · collaborator · 2023-11-19
RECRUITING
Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Trial)NCT07510685 · collaborator · 2025-02-01
COMPLETED
Italian Lung Cancer Observational StudyNCT05851755 · collaborator · 2023-04-01
ENROLLING_BY_INVITATION
Precision Medicine for Preventing Type 2 Diabetes: a Step ForwardNCT05147961 · collaborator · 2022-05-25
UNKNOWN
Obesity Surgery During 2020 Italian PandemicNCT04480034 · collaborator · 2020-07-15
UNKNOWN
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?NCT06251830 · collaborator · 2018-09-01
COMPLETED
Robot-assisted Gait Training in Multiple Sclerosis SubjectsNCT01435694 · collaborator · 2011-04-01
COMPLETED
Multicentric Prospective Randomized Trial on Surgery Versus Standard Medical Care in Type 2 Diabetic Patients BMI 30-35NCT01041768 · collaborator · 2009-03-01
UNKNOWN

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Azienda Ospedaliero, Universitaria Pisana as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor14
collaborator9
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.